Complying with the Sunshine Act could be costly

04/29/2012 | MedCityNews.com

Drug and device makers could end up paying upwards of $200,000 in the first year the federal Sunshine Act is in force -- not including legal fees and information technology upgrades, lawyer Sheva Sanders said at a LifeScience Alley conference. Seven states and the District of Columbia have laws regarding disclosure of financial relationships between manufacturers and health care providers, with varying fees and requirements.

View Full Article in:

MedCityNews.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA